Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III StudyTaishi Hata, Hidetoshi Eguchi, Mamoru Uemura et al.|The Oncologist|2021Cited by 8
Phase III Study on the Administration Method of Adjuvant UFT and Leucovorin Calcium in Patients with Resected Colorectal Cancer (Thrice-Daily versus Twice-Daily Regimen)Taishi Hata, Hidetoshi Eguchi, Masakazu Miyake et al.|SSRN Electronic Journal|2020Cited by 0
A twice-daily or a three-times-daily tegafur-uracil and leucovorin calcium regimen as adjuvant therapy in patients with resected colorectal cancer: A phase III study.Kazuya Iwamoto, Hidetoshi Eguchi, Taishi Hata et al.|Journal of Clinical Oncology|2022Cited by 0
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of adjuvant XELOX in Japanese patients Taishi Hata, Hidetoshi Eguchi, M. Umemura et al.|Research Square|2024Cited by 0
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancerTaishi Hata, Hidetoshi Eguchi, Mamoru Uemura et al.|Scientific Reports|2024Cited by 0